Cytosystems is committed to working with industrial and scientific partners in order to successfully commercialise its laboratory-based MCM technology for the early diagnosis of bladder cancer.
For an update on progress, please contact:
Richard Berry
Chief Executive
Cytosystems Ltd
Cruickshank Building
Craibstone
Aberdeen AB21 9TR
Scotland , UK
